Amyris, Inc. (NASDAQ:AMRS)

CAPS Rating: 2 out of 5

Results 1 - 13 of 13

Recs

1
Member Avatar rbitrage (66.52) Submitted: 10/13/2014 9:56:10 PM : Underperform Start Price: $3.13 AMRS Score: +37.08

No tangible book. No profits in the last year and no earnings in the last year. Currently anything speculative is being punished severely in the market. Expect AMRS to be punished, too.

Recs

3
Member Avatar MaxPower13 (96.54) Submitted: 3/24/2014 12:31:00 PM : Outperform Start Price: $3.61 AMRS Score: -48.88

Just read Maxx's article. http://www.fool.com/investing/general/2014/03/12/can-amyris-inc-save-deep-sea-sharks-and-expand-thi.aspx At this price, I think it's worth taking a shot.

Recs

0
Member Avatar SqwiiTrader (< 20) Submitted: 2/18/2014 2:17:46 AM : Outperform Start Price: $3.67 AMRS Score: -50.27

Senholt

Recs

0
Member Avatar rknapton (< 20) Submitted: 7/23/2013 8:22:55 PM : Underperform Start Price: $2.82 AMRS Score: +41.14

Short. Former Biopharma company, now specialty chem. Revs down 73% Issuing tons of stock and debt.

Recs

0
Member Avatar oregonpb (49.44) Submitted: 2/16/2012 12:04:36 PM : Outperform Start Price: $6.20 AMRS Score: -115.67

Biofuel>> until the company produces for the market it will be speculative, but when it does it might be too late to get in ~early.

Recs

0
Member Avatar powerkiwi (< 20) Submitted: 1/23/2012 4:46:30 PM : Outperform Start Price: $10.46 AMRS Score: -136.19

Its a strong company with many potential technologies. Green tech is growing rapidly

Recs

0
Member Avatar GeoSteam (< 20) Submitted: 1/20/2012 11:15:36 PM : Outperform Start Price: $10.41 AMRS Score: -135.23

It is a biochemical company which can turn plant sugars into more valuable commodities using designer microbes, an entirely new human capability. The company is ran by idealistic, practical leaders, with special strength in several nations, e.g. Brazil.

Recs

0
Member Avatar phboyer (< 20) Submitted: 9/30/2011 2:16:55 PM : Outperform Start Price: $19.85 AMRS Score: -169.25

AMRS is undervalued at these levels. There is resistance at the $20.50 level. If it breaks $21 is could squirt all the way to $30 in no time. They are well backed and respected in the VC community.

Recs

0
Member Avatar korhonen (67.42) Submitted: 2/20/2011 1:48:27 PM : Outperform Start Price: $29.97 AMRS Score: -147.56

On the cusp of profitability and have gained capital through the IPO.

Recs

1
Member Avatar EclecticRecluse (80.31) Submitted: 1/30/2011 3:37:38 AM : Underperform Start Price: $31.12 AMRS Score: +153.96

Weakening Earnings Opinion

Recs

0
Member Avatar TMFRisingStars (22.61) Submitted: 1/28/2011 11:39:18 AM : Outperform Start Price: $31.70 AMRS Score: -153.74

Here's the buy rec:
http://www.fool.com/investing/high-growth/2011/01/27/rising-star-buy-amyris-biotechnologies.aspx

Recs

3
Member Avatar TheGrtGdOM (59.07) Submitted: 11/6/2010 3:01:07 PM : Outperform Start Price: $17.38 AMRS Score: -155.75

The long term arc is that oil is going to cost more and more to extract. This company's products OTOH need no refining and have an abundantly available feedstock. They can be shunted into pathways for use as gasoline, diesel, or jet fuel substitutes and exceed the original's performance. And eventually aviation will be charged for its carbon emissions as well, justifying an additional premium for this alternative.

Meanwhile the company will eke by at first by producing other specialty products as they get their production costs down and the costs of oil and associated with its use go up. I suspect that "capital light" may even eventually mean selling just the bugs as IP.

A long term play but worth it for an investor with tolerance for risk and a long term horizon.

Recs

2
Member Avatar notUSA (22.51) Submitted: 11/3/2010 6:43:28 PM : Outperform Start Price: $17.15 AMRS Score: -159.41

reports their ( at $16.00) first quarterly earnings report since their IPO(October 2, 2010) on November 4th after the close.. They will be touting , I'm sure , how far along they are in their new biofuel facilities in Brazil, as well as their joint venture partners, Vale, as well as other important companies invested with them. A video will be played 2 hrs after the report on their website.

Results 1 - 13 of 13

Featured Broker Partners


Advertisement